Viemed Healthcare Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Revenue	183.01	138.83	117.06	131.31	80.26	64.46	46.93
Revenue Growth (YoY)	31.82%	18.60%	-10.85%	63.61%	24.50%	37.37%	-
Cost of Revenue	70.23	54.15	43.65	51.2	24.25	16.69	12.31
Gross Profit	112.78	84.68	73.41	80.11	56.01	47.78	34.62
Selling, General & Admin	87.88	68.16	54.89	52.83	41.38	34.3	24.56
Research & Development	2.78	2.7	2.11	1.08	0.85	0	0
Other Operating Expenses	7.79	5.57	4.83	-0.58	4.56	3.42	1.43
Operating Expenses	98.45	76.43	61.83	53.33	46.79	37.72	25.99
Operating Income	14.33	8.25	11.58	26.78	9.22	10.06	8.62
Interest Expense / Income	0.42	0.2	0.32	0.51	0.31	0.18	0.27
Other Expense / Income	-0.49	-0.94	-1.24	-0.09	0.11	0.21	0.16
Pretax Income	14.39	8.99	12.5	26.36	8.8	9.67	8.19
Income Tax	4.15	2.77	3.38	-5.17	0.27	0.16	0.02
Net Income	10.24	6.22	9.13	31.53	8.53	9.51	8.18
Net Income Growth	64.63%	-31.82%	-71.06%	269.85%	-10.34%	16.29%	-
Shares Outstanding (Basic)	38	39	39	39	38	38	38
Shares Outstanding (Diluted)	40	40	41	41	40	40	38
Shares Change	1.44%	-2.15%	0.38%	1.96%	0.18%	4.49%	-
EPS (Basic)	0.27	0.16	0.23	0.81	0.23	0.25	0.22
EPS (Diluted)	0.25	0.16	0.22	0.78	0.21	0.24	0.22
EPS Growth	56.25%	-27.27%	-71.79%	271.43%	-12.50%	9.09%	-
Free Cash Flow	21.71	5.91	3.35	27.32	6.28	17.07	8.45
Free Cash Flow Per Share	0.57	0.15	0.09	0.70	0.17	0.45	0.22
Gross Margin	61.63%	60.99%	62.71%	61.01%	69.78%	74.11%	73.76%
Operating Margin	7.83%	5.94%	9.89%	20.40%	11.48%	15.60%	18.37%
Profit Margin	5.60%	4.48%	7.80%	24.01%	10.62%	14.75%	17.42%
Free Cash Flow Margin	11.86%	4.26%	2.86%	20.81%	7.82%	26.48%	18.01%
Effective Tax Rate	28.82%	30.79%	27.01%	-19.60%	3.08%	1.68%	0.18%
EBITDA	36.68	24.82	24.13	36.45	15.51	13.63	11.01
EBITDA Margin	20.04%	17.88%	20.62%	27.76%	19.33%	21.15%	23.45%
Depreciation & Amortization	21.86	15.63	11.31	9.58	6.4	3.78	2.54
EBIT	14.82	9.19	12.82	26.87	9.11	9.85	8.46
EBIT Margin	8.10%	6.62%	10.95%	20.46%	11.35%	15.28%	18.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).